The organization showcases scientific excellence in drug discovery and represents a major driver for health and the economy.
Based at the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal, IRICoR identifies and funds the most promising projects in Canada and from abroad. It also supports the research teams throughout the project maturation process in order to establish fruitful and sustainable co-development partnerships with industry or to create spinoff companies.